Digoxin-specific antibody fragments in the treatment of digoxin toxicity. - Wikidata - awgldk - TriplyDB

Digoxin-specific antibody fragments in the treatment of digoxin toxicity.

Digoxin-specific antibody fragments in the treatment of digoxin toxicity.

http://www.wikidata.org/entity/Q38236647

about

Management of digoxin toxicity Epidemiology and clinical features of ciguatera fish poisoning in Hong Kong.Pharmacological treatment of cardiac glycoside poisoning.Who gets antidotes? choosing the chosen few.Digoxin-induced retinal degeneration depends on rhodopsin.Extracorporeal treatment for digoxin poisoning: systematic review and recommendations from the EXTRIP Workgroup.Rising cost of antidotes in the U.S.: cost comparison from 2010 to 2015.Efficacy and effectiveness of anti-digoxin antibodies in chronic digoxin poisonings from the DORA study (ATOM-1).Efficient expression of single chain variable fragment antibody against paclitaxel using the Bombyx mori nucleopolyhedrovirus bacmid DNA system and its characterizations.Comprehensive review of cardiovascular toxicity of drugs and related agents.Comfrey herbal remedy causing second-degree heart block: do not be outfoxed by digitalis.A system-wide solution to antidote stocking in emergency departments: the Nova Scotia antidote program.Incomplete Antibodies May Reduce ABO Cross-Match Incompatibility: A Pilot Study.Forging the Fate of Cellular Therapies for Cardiovascular Disease.Authors’ responses to Letter to the Editor regarding ‘Early digoxin-specific antibody fragments to treat patients at risk of life-threatening toxicity’

P2860

Q26753003-7A1F33D2-D898-4252-B282-B031F48F3497 Q34411488-9B612754-366F-417B-8ED4-C62B40F41CB0 Q36618110-F44E2FC3-90F3-45CB-9F2E-CE1A53649945 Q36618128-1E4B9F55-DE29-45E1-A9F9-F9C3B36DB667 Q37745617-06F3E2FF-FDF4-4433-BEC5-7C029005F97F Q38706177-7A2802B9-CC86-45A2-B562-333658EC3207 Q38976817-C130B351-A46C-43B7-93A8-CCB7861CB857 Q39818756-E1D1A7BF-504C-4060-A8A2-927F15E0E3A1 Q40873211-494BB312-7D94-41AC-93A3-51D112EB477B Q47556269-41062024-2537-41B8-85C1-71004BEFC7C5 Q47788406-FFEC4A3D-C920-4AE2-82D0-5DA7A3B6EF6F Q47959673-EF6ECD38-B18E-4D83-A556-E41B480D4D6C Q50987486-AEE4F581-AEDA-456B-A6DF-BD52DCF39978 Q55229425-59994C66-3E3D-4299-B704-6F60D9DF196C Q57808634-E7976940-6CF2-4BAD-9FDA-86514565A054

P2860

Digoxin-specific antibody fragments in the treatment of digoxin toxicity.

http://www.wikidata.org/entity/Q38236647

description

2014 nî lūn-bûn

@nan

2014年の論文

@ja

2014年論文

@yue

2014年論文

@zh-hant

2014年論文

@zh-hk

2014年論文

@zh-mo

2014年論文

@zh-tw

2014年论文

@wuu

2014年论文

@zh

2014年论文

@zh-cn

name

Digoxin-specific antibody fragments in the treatment of digoxin toxicity.

@en

type

label

Digoxin-specific antibody fragments in the treatment of digoxin toxicity.

@en

prefLabel

Digoxin-specific antibody fragments in the treatment of digoxin toxicity.

@en

P1433

Q38236647-9FE3E234-CB1A-4AF4-85F7-2BA3B5A777FD

P1476

Q38236647-AE1EF85D-DF8B-49A6-8261-57FB8B35F72E

P2093

Q38236647-A5F7568F-A5ED-436B-AA7B-95CF9D2BD150

P2860

Q38236647-0C2D9644-488F-40E6-96A1-B002CF0722C2

Q38236647-14C6E7D3-F316-4289-A573-DAD6103C6DAC

Q38236647-183FAF97-A377-4F27-BBE2-90281CC78623

Q38236647-1FC5B365-595B-4CEB-8E61-1449353D5F37

Q38236647-26A209AD-E1C5-4374-9E49-06CCABFE6862

Q38236647-27BD5D5F-5665-4A97-B2EC-2BCF73FC27A9

Q38236647-2D1867B8-67B5-4F71-85F6-81070EEDD15B

Q38236647-2FE38CC9-C318-4A61-8091-E1ABF5BE0A35

Q38236647-30B280BA-4CE9-46F9-AF61-640FEC9AEB15

Q38236647-34A44FDE-2DD3-478E-A624-B0E8AFCB4D87

P304

Q38236647-8EB99DDE-4407-4633-9FA8-988F6C2D1527

P31

Q38236647-0ED1A10E-5708-42C3-82D3-14FA5D10CD6D

P356

Q38236647-39028E32-1444-4110-899D-5936321FF031

P407

Q38236647-675047CB-7EEB-4FB3-B11B-5D4D82A37A44

P433

Q38236647-D1C29E6E-367F-40FE-9679-236561E1A45E

P478

Q38236647-EA01424E-02EE-41BF-8070-5E25E1810331

P50

Q38236647-654E7091-DCC5-4578-AF6E-852E2A8856AB

P577

Q38236647-4E17C3C0-EF54-47EE-B7C6-F02D33A593B2

P5875

Q38236647-51FB2B2C-56ED-4B06-9CFE-0DF989D1CF60

P698

Q38236647-BF94EDC2-7FC3-4D17-AFB9-B202164BEFF9

P921

Q38236647-C2AB85C5-B2D7-46F3-9F54-CA30D4F7943A

P356

15563650.2014.943907

P1433

Clinical Toxicology

P1476

Digoxin-specific antibody fragments in the treatment of digoxin toxicity.

@en

P2093

B S H Chan

http://www.w3.org/2001/XMLSchema#string

P2860

Emergency hospitalizations for adverse drug events in older Americans

Fructose-1, 6-diphosphate (FDP) as a novel antidote for yellow oleander-induced cardiac toxicity: a randomized controlled double blind study.

Estimation of lean body weight in older community-dwelling men

Analysis of the use of digoxin immune fab for the treatment of non-life-threatening digoxin toxicity.

Treatment of 150 cases of life-threatening digitalis intoxication with digoxin-specific Fab antibody fragments. Final report of a multicenter study.

Fab antibody fragments: some applications in clinical toxicology.

Kinetics of digoxin and anti-digoxin antibody fragments during treatment of digoxin toxicity.

The bioavailability of digoxin from three oral formulations measured by a specific h.p.l.c. assay

Treatment of toad venom poisoning with digoxin-specific Fab fragments.

Digoxin-specific antibodies

P304

824-836

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.3109/15563650.2014.943907

http://www.w3.org/2001/XMLSchema#string

P407

P433

8

http://www.w3.org/2001/XMLSchema#string

P478

52

http://www.w3.org/2001/XMLSchema#string

P50

Nicholas A. Buckley

P577

2014-08-04T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

264462822

http://www.w3.org/2001/XMLSchema#string

P698

25089630

http://www.w3.org/2001/XMLSchema#string

P921